Fundz
An acquisition means integration work is about to be scoped. Fundz scores the company against what you sell, and says why it matched.See it live →

Huadeng Tech proposes to acquire 111 Inc.

PRIVATESep 17, 2026•about 3 hours ago

Acquiring Company

Huadeng Tech BioArray Ventures Ltd

Acquired Company

111

ShanghaiBiotechnologyHealth CareVenture CapitalHealth Care

Description

111 Inc. received an unsolicited proposal to be acquired by Huadeng Tech BioArray Ventures Ltd. The proposal includes a cash purchase price of $0.226 per Class A share. The acquisition aims to take the company private in a going-private transaction. The Board has yet to evaluate this proposal and its conditions.

Company Information

Company

Huadeng Tech BioArray Ventures Ltd

About

Huadeng Tech BioArray Ventures Ltd is a venture company involved in financing technology and healthcare platforms. It works with other firms to invest in innovative solutions in the biotech sector. The company focuses on supporting companies that show promise in improving health outcomes.

Don't miss Huadeng Tech BioArray Ventures Ltd's next move

Get an email the moment Huadeng Tech BioArray Ventures Ltd makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Huadeng Tech BioArray Ventures Ltd's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired 111?

111 was acquired by Huadeng Tech BioArray Ventures Ltd. The deal was reported on September 17, 2026. Huadeng Tech BioArray Ventures Ltd is a venture company involved in financing technology and healthcare platforms. It works with other firms to invest in innovative solutions in the biotech sector. Huadeng Tech BioArray Ventures Ltd is privately held and operates in Biotechnology.

When did Huadeng Tech BioArray Ventures Ltd acquire 111?

Huadeng Tech BioArray Ventures Ltd's acquisition of 111 was reported on September 17, 2026. 111 Inc. received an unsolicited proposal to be acquired by Huadeng Tech BioArray Ventures Ltd. The proposal includes a cash purchase price of $0.226 per Class A share. The acquisition aims to take the company private in a going-private transaction. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does 111 do?

111, Inc. is a leading tech-enabled healthcare platform company in China, dedicated to reshaping the healthcare industry value chain. It integrates digital solutions to empower both upstream and downstream operations. It is publicly traded (YI), operating in Health Care, and is based in Shanghai.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.